Angiotensin receptor blockers for hypertension
Pro Research Analysisby 
Searched over 200M research papers
Angiotensin Receptor Blockers (ARBs) for Hypertension: Efficacy and Safety
Angiotensin receptor blockers (ARBs) are widely recommended as a first-line treatment for hypertension in both US and European guidelines, alongside ACE inhibitors (ACEIs), calcium channel blockers, and thiazide diuretics. ARBs are effective in lowering blood pressure and are known for their favorable safety and tolerability profile compared to other antihypertensive agents 12.
Blood Pressure Lowering and Comparative Efficacy
Multiple studies have shown that ARBs are as effective as ACEIs in reducing blood pressure in patients with hypertension 1467. Network meta-analyses comparing different ARBs found that olmesartan and candesartan are among the most effective in lowering both office and ambulatory blood pressure, while valsartan and losartan are somewhat less effective, though differences are not large . Combining ARBs with thiazide diuretics or calcium channel blockers further enhances blood pressure control, especially in patients who do not achieve target levels with monotherapy 29.
Cardiovascular and Renal Protection
ARBs not only lower blood pressure but also provide protection against cardiovascular and renal damage. They are particularly beneficial for patients with heart failure or diabetic renal disease, especially for those who cannot tolerate ACEIs 12. However, some evidence suggests that ACEIs may be slightly superior to ARBs in reducing cardiovascular events and all-cause mortality, though both drug classes are similar in their ability to lower blood pressure 467.
Safety and Tolerability of ARBs
ARBs are generally very well tolerated, with fewer adverse effects compared to ACEIs. The most notable difference is a lower incidence of dry cough and angioedema with ARBs, making them a preferred option for patients who experience these side effects with ACEIs 1467. In pediatric populations, ARBs have also been shown to be effective and safe, with most side effects being mild and infrequent .
ARBs in Special Populations and Combination Therapy
In elderly, high-risk patients, combining an ARB with a calcium channel blocker is more effective at lowering blood pressure and reducing cardiovascular events than simply increasing the dose of the ARB alone . This supports the use of combination therapy in patients who require additional blood pressure control.
Additional Benefits Beyond Hypertension
ARBs have protective effects beyond blood pressure control, including reducing inflammation, protecting endothelial and mitochondrial function, and improving insulin sensitivity. These properties may be beneficial in treating other conditions such as metabolic and neurodegenerative disorders 510. During the COVID-19 pandemic, ARBs have been noted for their potential to protect the lungs and reduce inflammation, and it is recommended that patients continue ARB therapy if they have hypertension or related comorbidities 110.
Conclusion
ARBs are a highly effective and well-tolerated option for managing hypertension, with efficacy comparable to ACEIs and a better side effect profile. They offer additional cardiovascular and renal protection, and their use is supported in both adult and pediatric populations. Combination therapy with ARBs and other antihypertensive agents can further improve outcomes, especially in high-risk patients. Overall, ARBs represent an excellent choice for the management of hypertension and its complications 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic